These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 15116294

  • 1. Relationship between fluoroquinolone area under the curve: minimum inhibitory concentration ratio and the probability of eradication of the infecting pathogen, in patients with nosocomial pneumonia.
    Drusano GL, Preston SL, Fowler C, Corrado M, Weisinger B, Kahn J.
    J Infect Dis; 2004 May 01; 189(9):1590-7. PubMed ID: 15116294
    [Abstract] [Full Text] [Related]

  • 2. Characterization of the onset and consequences of pneumonia due to fluoroquinolone-susceptible or -resistant Pseudomonas aeruginosa.
    Paladino JA, Sunderlin JL, Forrest A, Schentag JJ.
    J Antimicrob Chemother; 2003 Sep 01; 52(3):457-63. PubMed ID: 12888598
    [Abstract] [Full Text] [Related]

  • 3. Pneumonia due to Pseudomonas aeruginosa: the levofloxacin clinical trials experience.
    Tennenberg AM, Davis NB, Wu SC, Kahn J.
    Curr Med Res Opin; 2006 May 01; 22(5):843-50. PubMed ID: 16709306
    [Abstract] [Full Text] [Related]

  • 4. In nosocomial pneumonia, optimizing antibiotics other than aminoglycosides is a more important determinant of successful clinical outcome, and a better means of avoiding resistance.
    Schentag JJ, Birmingham MC, Paladino JA, Carr JR, Hyatt JM, Forrest A, Zimmer GS, Adelman MH, Cumbo TJ.
    Semin Respir Infect; 1997 Dec 01; 12(4):278-93. PubMed ID: 9436955
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pseudomonas aeruginosa, Staphylococcus aureus, and fluoroquinolone use.
    MacDougall C, Harpe SE, Powell JP, Johnson CK, Edmond MB, Polk RE.
    Emerg Infect Dis; 2005 Aug 01; 11(8):1197-204. PubMed ID: 16102307
    [Abstract] [Full Text] [Related]

  • 7. A retrospective analysis of possible renal toxicity associated with vancomycin in patients with health care-associated methicillin-resistant Staphylococcus aureus pneumonia.
    Jeffres MN, Isakow W, Doherty JA, Micek ST, Kollef MH.
    Clin Ther; 2007 Jun 01; 29(6):1107-15. PubMed ID: 17692725
    [Abstract] [Full Text] [Related]

  • 8. Risk of developing pneumonia is enhanced by the combined traits of fluoroquinolone resistance and type III secretion virulence in respiratory isolates of Pseudomonas aeruginosa.
    Sullivan E, Bensman J, Lou M, Agnello M, Shriner K, Wong-Beringer A.
    Crit Care Med; 2014 Jan 01; 42(1):48-56. PubMed ID: 23963124
    [Abstract] [Full Text] [Related]

  • 9. [The impact of antibiotic use on hospital-acquired pneumonia: data of etiology tests].
    Vitkauskiene A, Sakalauskas R, Dudzevicius V.
    Medicina (Kaunas); 2003 Jan 01; 39(3):254-9. PubMed ID: 12695638
    [Abstract] [Full Text] [Related]

  • 10. [Bacterial etiology of nosocomial pneumonia and antimicrobial resistance in patients with and without antimicrobial treatment].
    Weyland B, Perazzi B, García S, Rodríguez C, Vay C, Famiglietti A.
    Rev Argent Microbiol; 2011 Jan 01; 43(1):18-23. PubMed ID: 21491061
    [Abstract] [Full Text] [Related]

  • 11. [A retrospective cohort study of the influence of time of hospital-acquired pneumonia onset on pathogen constitution].
    Hu BJ, Wei L, Zhang XZ, Tang YC, Ni YX, Li YM, Guo JQ, Hu YJ, Zhang KX, Yang L.
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb 01; 28(2):112-6. PubMed ID: 15854394
    [Abstract] [Full Text] [Related]

  • 12. Intravenous polymyxin B for the treatment of nosocomial pneumonia caused by multidrug-resistant Pseudomonas aeruginosa.
    Furtado GH, d'Azevedo PA, Santos AF, Gales AC, Pignatari AC, Medeiros EA.
    Int J Antimicrob Agents; 2007 Oct 01; 30(4):315-9. PubMed ID: 17631984
    [Abstract] [Full Text] [Related]

  • 13. Methicillin-resistant Staphylococcus aureus pneumonia after thoracic surgery: successful treatment with linezolid after failed vancomycin therapy.
    Salerno D, Vahid B, Marik PE.
    Ann Thorac Surg; 2007 May 01; 83(5):1888-91. PubMed ID: 17462428
    [Abstract] [Full Text] [Related]

  • 14. A holistic approach to MRSA eradication in critically ill patients with MRSA pneumonia.
    Wenisch C, Laferl H, Szell M, Smolle KH, Grisold A, Bertha G, Krause R.
    Infection; 2006 Jun 01; 34(3):148-54. PubMed ID: 16804658
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of area under the inhibitory curve (AUIC) and time above the minimum inhibitory concentration (T>MIC) as predictors of outcome for cefepime and ceftazidime in serious bacterial infections.
    McKinnon PS, Paladino JA, Schentag JJ.
    Int J Antimicrob Agents; 2008 Apr 01; 31(4):345-51. PubMed ID: 18313273
    [Abstract] [Full Text] [Related]

  • 16. Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.
    Kohno S, Yamaguchi K, Aikawa N, Sumiyama Y, Odagiri S, Aoki N, Niki Y, Watanabe S, Furue M, Ito T, Croos-Dabrera R, Tack KJ.
    J Antimicrob Chemother; 2007 Dec 01; 60(6):1361-9. PubMed ID: 17913720
    [Abstract] [Full Text] [Related]

  • 17. Device-associated nosocomial infection rates in intensive care units of seven Indian cities. Findings of the International Nosocomial Infection Control Consortium (INICC).
    Mehta A, Rosenthal VD, Mehta Y, Chakravarthy M, Todi SK, Sen N, Sahu S, Gopinath R, Rodrigues C, Kapoor P, Jawali V, Chakraborty P, Raj JP, Bindhani D, Ravindra N, Hegde A, Pawar M, Venkatachalam N, Chatterjee S, Trehan N, Singhal T, Damani N.
    J Hosp Infect; 2007 Oct 01; 67(2):168-74. PubMed ID: 17905477
    [Abstract] [Full Text] [Related]

  • 18. Hospital-acquired pneumonia in critically ill patients: factors associated with episodes due to imipenem-resistant organisms.
    Leroy O, d'Escrivan T, Devos P, Dubreuil L, Kipnis E, Georges H.
    Infection; 2005 Jun 01; 33(3):129-35. PubMed ID: 15940413
    [Abstract] [Full Text] [Related]

  • 19. Levofloxacin compared with imipenem/cilastatin followed by ciprofloxacin in adult patients with nosocomial pneumonia: a multicenter, prospective, randomized, open-label study.
    West M, Boulanger BR, Fogarty C, Tennenberg A, Wiesinger B, Oross M, Wu SC, Fowler C, Morgan N, Kahn JB.
    Clin Ther; 2003 Feb 01; 25(2):485-506. PubMed ID: 12749509
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.